Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New nasal cannula aims to ease breathing in COPD emergencies

NCT ID NCT05829083

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 25 times

Summary

This study compares a new asymmetric nasal high-flow interface to a standard nasal cannula in 50 people with mild-to-moderate COPD flare-ups. The goal is to see if the new device lowers carbon dioxide levels, reduces breathing rate, and improves comfort. Each participant will try both devices for 3 hours, with a 30-minute break in between.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sotiria General Hospital

    RECRUITING

    Athens, 11527, Greece

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Hospital of Larissa

    RECRUITING

    Larissa, 41110, Greece

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.